PagodaTree Partners

About

Puda Capital (朴道资本), founded in 2019, is a boutique private fund manager focused on healthcare and technology innovation industries. It was named one of the "Top 10 Emerging Venture Capital Institutions in China" on the 2022 Zero2IPO list, one of the "Top 50 Best VC Funds of 2023" by the Fund of Funds Research Center, and "Biopharma Investment Institution of the Year 2024" by Vcbeat (动脉网). Upholding the philosophy of "Puda helping the world" (朴道济世), it practices social responsibility. Its investors include well-known institutional investors and entrepreneurs such as China's leading market-oriented funds of funds and family offices. The core management team comes from top international investment institutions and has extensive industry resources and an international vision in healthcare and technology innovation industries. The team has rich experience in China and cross-border M&A, growth-stage and early-stage investment, capital markets and operations management. Puda Capital focuses on healthcare and life sciences, technology innovation and related frontier cross-disciplinary fields, actively participates in special investment opportunities, works closely with entrepreneurs to create value together, and builds the Puda Capital ecosystem.